AnaptysBio (ANAB) PT Lowered to $93 at Piper Sandler
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $59.78 +2.24%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi lowered the price target on AnaptysBio (NASDAQ: ANAB) to $93.00 (from $95.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
- Alchip Technologies Ltd (3661:TT) PT Lowered to NT$5,300 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
